Science Explorer Back to mapMap
Discussion
Company · Newton · United States

BioAxone BioSciences (United States)

Research works
13
▲ 3% vs 2018-21
Citations
316
24.2 per fractional work
Top-10% rate
6.5%
all institutions 10.0%
Open access
46%
world 40%
International
42%
world 18%

Not ranked overall: BioAxone BioSciences (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does BioAxone BioSciences (United States) work in?

In all years, 48% of research at BioAxone BioSciences (United States) is in Health Sciences, 39% in Life Sciences. Its largest fields are Medicine (48%), Biochemistry, Genetics and Molecular Biology (20%), Neuroscience (19%). It does 1.6× the world's share of Life Sciences.

Health Sciences: 6 fractional works · 48.2% of its workMedicine: 6 fractional works · 47.9% of its workPathology and Forensic Medicine: 1 fractional works · 10.2% of its workNeurology: 1 fractional works · 8.7% of its workGenetics: 1 fractional works · 8.5% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 5.5% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 4.4% of its workSurgery: 0 fractional works · 2.7% of its workOncology: 0 fractional works · 2.0% of its workReproductive Medicine: 0 fractional works · 1.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.3% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.8% of its workOtorhinolaryngology: 0 fractional works · 0.8% of its workPsychiatry and Mental health: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workLife Sciences: 5 fractional works · 39.1% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 20.0% of its workMolecular Biology: 1 fractional works · 10.8% of its workPhysiology: 1 fractional works · 5.1% of its workCancer Research: 0 fractional works · 2.9% of its workCell Biology: 0 fractional works · 0.6% of its workAging: 0 fractional works · 0.5% of its workNeuroscience: 2 fractional works · 18.6% of its workCellular and Molecular Neuroscience: 2 fractional works · 12.1% of its workDevelopmental Neuroscience: 1 fractional works · 4.9% of its workNeurology: 0 fractional works · 1.6% of its workAgricultural and Biological Sciences: 0 fractional works · 0.5% of its workInsect Science: 0 fractional works · 0.5% of its workSocial Sciences: 1 fractional works · 7.6% of its workPsychology: 1 fractional works · 7.6% of its workClinical Psychology: 1 fractional works · 7.6% of its workPhysical Sciences: 1 fractional works · 5.1% of its workPhysics and Astronomy: 0 fractional works · 2.5% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 1.3% of its workRadiation: 0 fractional works · 1.3% of its workEngineering: 0 fractional works · 1.3% of its workBiomedical Engineering: 0 fractional works · 1.3% of its workMathematics: 0 fractional works · 1.3% of its workModeling and Simulation: 0 fractional works · 1.3% of its workALL ITS WORKBioAxoneBioSciences…13fractional works, all years
Life Sciences39%Physical Sciences5%Health Sciences48%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Medicine647.9%
    2. Nursing00.3%
    1. Biochemistry, Genetics and Molecular Biology320.0%
    2. Neuroscience218.6%
    3. Agricultural and Biological Sciences00.5%
    1. Psychology17.6%
    1. Physics and Astronomy02.5%
    2. Engineering01.3%
    3. Mathematics01.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at BioAxone BioSciences (United States)?

Ranked on the quality score, John F. Cronin lead among researchers whose main affiliation is BioAxone BioSciences (United States).

  1. 1 John F. Cronin United States · #3,278,800 worldwide 353 citations · 61 works
All ranked researchers at BioAxone BioSciences (United States)

What are the most cited papers from BioAxone BioSciences (United States)?

The most cited paper from BioAxone BioSciences (United States) is "Local Inhibition of Rho Signaling by Cell-Permeable Recombinant Protein BA-210 Prevents Secondary Damage and Promotes Functional Recovery following Acute Spinal Cord Injury" (Stephanie Lord-Fontaine, Fan Yang, Quy N. Diep et al., 2008), with 124 citations. Next come "Rho Inhibitor VX-210 in Acute Traumatic Subaxial Cervical Spinal Cord Injury: Design of the SPinal Cord Injury Rho INhibition InvestiGation (SPRING) Clinical Trial" (100) and "MAG, myelin and overcoming growth inhibition in the CNS" (100).

Most cited papers
#PaperReleasedCitations
1 Local Inhibition of Rho Signaling by Cell-Permeable Recombinant Protein BA-210 Prevents Secondary Damage and Promotes Functional Recovery following Acute Spinal Cord Injury Stephanie Lord-Fontaine, Fan Yang, Quy N. Diep et al. · Journal of Neurotrauma Nov 2008 124
2 Rho Inhibitor VX-210 in Acute Traumatic Subaxial Cervical Spinal Cord Injury: Design of the SPinal Cord Injury Rho INhibition InvestiGation (SPRING) Clinical Trial Michael George Fehlings, Kee D. Kim, Bizhan Aarabi et al. · Journal of Neurotrauma Open access 10 Jan 2018 100
3 MAG, myelin and overcoming growth inhibition in the CNS Lisa J. McKerracher, Kenneth M. Rosen · Frontiers in Molecular Neuroscience Open access 7 Sep 2015 100
4 A Randomized Controlled Trial of Local Delivery of a Rho Inhibitor (VX-210) in Patients with Acute Traumatic Cervical Spinal Cord Injury Michael George Fehlings, Yang Chen, Bizhan Aarabi et al. · Journal of Neurotrauma Open access 9 Feb 2021 59
5 Analysis of Recruitment and Outcomes in the Phase I/IIa Cethrin Clinical Trial for Acute Spinal Cord Injury Lisa J. McKerracher, Kim D. Anderson · Journal of Neurotrauma 11 Jul 2013 52
All 28 most cited papers, with filters and sorting

Which research topics does BioAxone BioSciences (United States) publish most on?

By volume in 2022-now: Ovarian cancer diagnosis and treatment, Cancer-related molecular mechanisms research, Molecular Biology Techniques and Applications and Neurosurgical Procedures and Complications.

  1. 1 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
  2. 2 Cancer-related molecular mechanisms research Cancer Research 0 works
  3. 3 Molecular Biology Techniques and Applications Molecular Biology 0 works
  4. 4 Neurosurgical Procedures and Complications Neurology 0 works
  5. 5 Intracerebral and Subarachnoid Hemorrhage Research Neurology 0 works
  6. 6 Forensic Entomology and Diptera Studies Insect Science 0 works
  7. 7 Extracellular vesicles in disease Molecular Biology 0 works
  8. 8 Cancer Genomics and Diagnostics Cancer Research 0 works
  9. 9 RNA Interference and Gene Delivery Molecular Biology 0 works
  10. 10 RNA regulation and disease Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.2%not open53.8%

World: 40% of research is openly available.

with international co-authors42.0%domestic only58.0%

World: 18% is written across borders.

How has BioAxone BioSciences (United States)'s research output changed?

Output in 2022-2025 was 3% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is BioAxone BioSciences (United States) as a percentage of every work published that year, 0.0000024% in 2024.

still counting0.000020%0.000040%0.000060%BioAxone BioSciences (United States)0.000017% in 202520102020

Fractional works of BioAxone BioSciences (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Newton

All research institutions in Newton

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about BioAxone BioSciences (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.